Details for Patent: 8,846,906
✉ Email this page to a colleague
Title: | 5HT.sub.2C receptor modulators |
Abstract: | The present invention relates to novel compounds of Formula (I): ##STR00001## which act as 5HT.sub.2C receptor modulators. These compounds are useful in pharmaceutical compositions whose use includes the treatment of obesity. |
Inventor(s): | Smith; Jeffrey (San Diego, CA), Smith; Brian (San Diego, CA) |
Assignee: | Arena Pharmaceuticals, Inc. (San Diego, CA) |
Filing Date: | Sep 14, 2012 |
Application Number: | 13/616,981 |
Claims: | 1. The compound that is N-trifluoroacetyl-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. 2. The compound that is N-trifluoroacetyl-8-chloro-1-methylene-2,3,4,5-tetrahydro-1H-3-benzazepin- e. |